AI assistant
Twist Bioscience Corp — Director's Dealing 2019
Nov 5, 2019
31873_dirs_2019-11-05_ee537555-5640-4e25-a4e3-1c7547a2d33f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2019-10-24
Reporting Person: Green Paula (VP of Human Resources)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-10-24 | Common Stock | A | 6490 | $0.00 | Acquired | 23903 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-10-24 | Employee Stock Option (right to buy) | $23.33 | A | 27800 | Acquired | 2029-10-23 | Common Stock (27800) | Direct |
Footnotes
F1: Represents a restricted stock unit award (the "RSU Award") that vests in installments, with 25% of the shares subject to the RSU Award vesting on October 24, 2020 and 1/16th of the shares subject to the RSU Award vesting on each quarterly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F2: Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F3: 25% of the shares subject to the option vest and become exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuing service through each vesting date.